Vyriad is developing the next generation of targeted cancer therapies using engineered viruses that selectively attack cancer cells and ignite robust immune responses to prevent cancer recurrence.
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
2 followers
Eikon Therapeutics
4 followers
Gilead Sciences
213 followers
Regeneron
181 followers
Illumina
92 followers
Agilent Technologies
101 followers
Verily Life Sciences
49 followers
Alexion Pharmaceuticals
56 followers
GRAIL
36 followers